Skip to Content
Merck

MAB8251

Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend

ascites fluid, Chemicon®, from mouse

Sign In to View Organizational & Contract Pricing

Select a Size

100 μL

£453.00

£453.00


Estimated to ship TODAYDetails

A recombinant, preservative-free antibody is available for your target. Try ZMS1020

Request a Bulk Order

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

Quality Level

antibody form

ascites fluid

antibody product type

primary antibodies

clone

A1, monoclonal
A3, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG1 (A3)
IgG2a (A1)

shipped in

wet ice

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
MAB8661MAB8257MAB8257B
biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

antibody form

ascites fluid

antibody form

ascites fluid

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

clone

A1, monoclonal, A3, monoclonal

clone

B2, monoclonal, B4, monoclonal

clone

A1, monoclonal

clone

A1, monoclonal

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

Immunogen

Influenza A blend.

Application

Indirect immunofluorescence at 1:100-1:1000.

Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend is validated for use in IF for the detection of Influenza A.

Biochem/physiol Actions

All subtypes of Influenza A (H1N1, H2N2 and H3N2 and H5N1). Specific for the nucleoprotein antigen. No cross-reactivity seen to Influenza B, Parainfluenza 1, 2 or Adenovirus or RSV.

Physical form

Ascites fluid containing no preservatives.
Unpurified

Preparation Note

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
Influenza Control Slides, Catalogue Number 5010-5

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tissue tropism of a Thailand strain of high-pathogenicity avian influenza virus (H5N1) in tissues of naturally infected native chickens (Gallus gallus), Japanese quail (Coturnix coturnix japonica) and ducks (Anas spp.).
Chongmas Antarasena, Rungtiva Sirimujalin, Porntip Prommuang, Stuart D Blacksell et al.
Avian Pathology : Journal of the W.V.P.A null
Donald D Raymond et al.
Nature medicine, 22(12), 1465-1469 (2016-11-08)
For broad protection against infection by viruses such as influenza or HIV, vaccines should elicit antibodies that bind conserved viral epitopes, such as the receptor-binding site (RBS). RBS-directed antibodies have been described for both HIV and influenza virus, and the
Shuguang Han et al.
Clinical and experimental pharmacology & physiology, 45(1), 84-93 (2017-08-31)
Curcumin, an active phenolic agent extract from the Curcuma longa, exhibits excellent anti-cancer, anti-inflammation, and neuroprotective effects. We aimed to investigate the anti-influenza role of curcumin in vitro and in vivo. The effect of curcumin on replication of influenza A
Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.
McCullers, JA; Van De Velde, LA; Allison, KJ; Branum, KC; Webby, RJ; Flynn, PM
Clinical Infectious Diseases null
Benjawan Khuntirat et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 69, 78-80 (2015-07-26)
Influenza A/H5N1 actively circulated in Kamphaeng Phet (KPP), Thailand from 2004 to 2006. A prospective longitudinal cohort study of influenza virus infection in 800 adults conducted during 2008-2010 in KPP suggested that subclinical or mild H5N1 infections had occurred among

Related Content

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service